| Detected | Trial | Change |
|---|---|---|
| 2026-08-07 | NCT05483868 A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer |
Enrollment closed, study ongoing |
| 2026-08-01 | NCT06007690 A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of… |
Enrollment closed, study ongoing |
| 2026-08-01 | NCT06007690 A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of… |
Trial sites reduced: 71 -> 66 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06007690 | A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of… | Choroidal Melanoma | Active, Not Recruiting |
| Phase 2 | |||
| NCT06643884 | Suprachoroidal Administration in Subjects With Metastases to the Choroid | Eye Cancer | Recruiting |
| Phase 1 | |||
| NCT05483868 | A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer | Non-muscle-invasive Bladder Cancer | Active, Not Recruiting |
| Not specified | |||
| NCT07421739 | Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301… | Choroidal Melanoma | Recruiting |
| NCT07338968 | A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early… | Choroidal Melanoma | Not Yet Recruiting |
| NCT03941379 | A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma | Choroidal Melanoma | Active, Not Recruiting |